“ϊ–{ˆγ‰Θ‘εŠwˆγŠw‰οŽGŽ Online Journal ƒƒCƒ“ƒiƒrƒQ[ƒVƒ‡ƒ“‚π”ς‚Ξ‚·
‘–ΪŽŸ > †–ΪŽŸ > Abstract ƒz[ƒ€‚Φ–ί‚ι
Abstract

‘ζ10Šͺ 2014”N6ŒŽ@‘ζ3†

‘S•ΆPDF (718K)

‘‘Žΰ

‹Ή•”H“ΉŠΰ‚Ι‘Ξ‚·‚ιŠO‰ΘŽ‘—Γ‚ΜŒ»‹΅
Ό’J@‹B1, –μ‘Ί@–±1, ”‹Œ΄@M•q1, –q–μ@_Ži2, ŠΫŽR@O2, ‹{‰Ί@³•v3, “ΰ“c@‰p“ρ1
1“ϊ–{ˆγ‰Θ‘εŠwŠO‰ΘŠwiΑ‰»ŠνŠO‰ΘŠwj
2“ϊ–{ˆγ‰Θ‘εŠw‘½–€‰iŽR•a‰@ŠO‰Θ
3“ϊ–{ˆγ‰Θ‘εŠwη—t–k‘•a‰@ŠO‰Θ

Current Surgical Treatment for Thoracic Esophageal Cancer
Takeshi Matsutani1, Tsutomu Nomura1, Nobutoshi Hagiwara1, Hiroshi Makino2, Hiroshi Maruyama2, Masao Miyashita3 and Eiji Uchida1
1)Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School
2)Department of Surgery, Nippon Medical School Tama Nagayama Hospital
3)Department of Surgery, Nippon Medical School Chiba Hokusoh Hospital

Esophageal squamous cell carcinoma is the sixth most common cause of cancer death in Japan. Surgery was previously the mainstay of treatment, but because of high rates of local and systemic recurrence, multidisciplinary management is being evaluated. In this article, we introduce the recent addition of neoadjuvant chemotherapy to the surgical management of resectable esophageal squamous cell carcinoma, clinical stage II and III, following the randomized control trial JCOG 9907. Neoadjuvant chemoradiotherapy has recently been approved for esophageal squamous cell carcinoma because it offers an opportunity for margin-negative resection, improved locoregional control, and increased survival rate. Less-invasive endoscopic procedures, such as thoracoscopic esophagectomy and laparoscopy-assisted gastric tube reconstruction, are options for the resection of noninvasive esophageal cancer. We performed thoracoscopic esophageal mobilization with the patient in the prone position. Compared with esophagectomy with right trans-thoracotomy, thoracoscopic esophagectomy has the advantage of a lower incidence of respiratory complications, which are a significant predictor of postoperative mortality. Additionally, other recent surgical treatments are described.

“ϊˆγ‘εˆγ‰οŽ 2014; 10(3), 134-141

Key words
esophageal carcinoma, neoadjuvant chemoradiotherapy, thoracoscopic esophagectomy

Correspondence to
Takeshi Matsutani, Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8603, Japan
E-mailFmatsutani@nms.ac.jp

Žσ•tF2014”N3ŒŽ24“ϊ@Žσ—F2014”N5ŒŽ8“ϊ

ƒƒCƒ“ƒiƒrƒQ[ƒVƒ‡ƒ“‚Φ–ί‚ι ‚±‚Μƒy[ƒW‚Μƒgƒbƒv‚Φ–ί‚ι